ID HFM1_HUMAN Reviewed; 1435 AA. AC A2PYH4; B1B0B6; Q8N9Q0; DT 18-MAR-2008, integrated into UniProtKB/Swiss-Prot. DT 23-SEP-2008, sequence version 2. DT 24-JAN-2024, entry version 138. DE RecName: Full=Probable ATP-dependent DNA helicase HFM1; DE EC=3.6.4.12; DE AltName: Full=SEC63 domain-containing protein 1; GN Name=HFM1; Synonyms=SEC3D1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND VARIANTS RP PRO-115 AND VAL-117. RX PubMed=17286053; DOI=10.1080/10425170600805433; RA Tanaka K., Miyamoto N., Shouguchi-Miyata J., Ikeda J.E.; RT "HFM1, the human homologue of yeast Mer3, encodes a putative DNA helicase RT expressed specifically in germ-line cells."; RL DNA Seq. 17:242-246(2006). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Uterus; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16710414; DOI=10.1038/nature04727; RA Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., RA Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., RA Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K., RA Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., RA Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., RA Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., RA Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., RA Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., RA Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., RA Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., RA Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., RA Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., RA Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., RA Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., RA Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., RA Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., RA Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., RA Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., RA McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., RA Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., RA Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., RA Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., RA Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., RA Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., RA White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., RA Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., RA Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., RA Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence and biological annotation of human chromosome 1."; RL Nature 441:315-321(2006). RN [4] RP POSSIBLE INVOLVEMENT IN POF9, AND VARIANTS POF9 SER-736 AND SER-884. RX PubMed=24597873; DOI=10.1056/nejmc1310150; RA Wang J., Zhang W., Jiang H., Wu B.L., Wu B.L., An Y., Wu B., Yu L., RA Zhou W., Jiang H., Zhang W., Song X., Zhang W., Jiang H., Wu J., Pu D., RA Zhang M., Wu B.L., Shen Y., Wu B.L., Wang J., Zhang W., Shen Y., Lin C., RA Grimmett L., Liao E., Shao H., Shen X., Platt O.; RT "Mutations in HFM1 in recessive primary ovarian insufficiency."; RL N. Engl. J. Med. 370:972-974(2014). CC -!- FUNCTION: Required for crossover formation and complete synapsis of CC homologous chromosomes during meiosis. {ECO:0000250|UniProtKB:D3Z4R1}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12; CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=A2PYH4-1; Sequence=Displayed; CC Name=2; CC IsoId=A2PYH4-2; Sequence=VSP_032249, VSP_032250, VSP_032251; CC -!- TISSUE SPECIFICITY: Preferentially expressed in testis and ovary. CC {ECO:0000269|PubMed:17286053}. CC -!- DISEASE: Premature ovarian failure 9 (POF9) [MIM:615724]: An ovarian CC disorder defined as the cessation of ovarian function under the age of CC 40 years. It is characterized by oligomenorrhea or amenorrhea, in the CC presence of elevated levels of serum gonadotropins and low estradiol. CC {ECO:0000303|PubMed:24597873}. Note=The disease may be caused by CC variants affecting the gene represented in this entry. CC -!- SIMILARITY: Belongs to the helicase family. SKI2 subfamily. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB204867; BAF45466.1; -; mRNA. DR EMBL; AK094079; BAC04281.1; -; mRNA. DR EMBL; AC098691; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BX323048; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR CCDS; CCDS30769.2; -. [A2PYH4-1] DR RefSeq; NP_001017975.4; NM_001017975.4. [A2PYH4-1] DR RefSeq; XP_011539151.1; XM_011540849.1. [A2PYH4-1] DR RefSeq; XP_011539152.1; XM_011540850.2. [A2PYH4-1] DR RefSeq; XP_011539153.1; XM_011540851.1. [A2PYH4-1] DR RefSeq; XP_011539154.1; XM_011540852.2. [A2PYH4-1] DR AlphaFoldDB; A2PYH4; -. DR SMR; A2PYH4; -. DR BioGRID; 127886; 125. DR STRING; 9606.ENSP00000359454; -. DR GlyGen; A2PYH4; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; A2PYH4; -. DR PhosphoSitePlus; A2PYH4; -. DR BioMuta; HFM1; -. DR EPD; A2PYH4; -. DR MassIVE; A2PYH4; -. DR PaxDb; 9606-ENSP00000359454; -. DR PeptideAtlas; A2PYH4; -. DR ProteomicsDB; 456; -. [A2PYH4-1] DR ProteomicsDB; 457; -. [A2PYH4-2] DR Antibodypedia; 51797; 141 antibodies from 19 providers. DR DNASU; 164045; -. DR Ensembl; ENST00000370425.8; ENSP00000359454.3; ENSG00000162669.16. [A2PYH4-1] DR GeneID; 164045; -. DR KEGG; hsa:164045; -. DR MANE-Select; ENST00000370425.8; ENSP00000359454.3; NM_001017975.6; NP_001017975.5. DR UCSC; uc001doa.4; human. [A2PYH4-1] DR AGR; HGNC:20193; -. DR CTD; 164045; -. DR DisGeNET; 164045; -. DR GeneCards; HFM1; -. DR HGNC; HGNC:20193; HFM1. DR HPA; ENSG00000162669; Tissue enhanced (pituitary gland, testis). DR MalaCards; HFM1; -. DR MIM; 615684; gene. DR MIM; 615724; phenotype. DR neXtProt; NX_A2PYH4; -. DR OpenTargets; ENSG00000162669; -. DR Orphanet; 619; NON RARE IN EUROPE: Primary ovarian failure. DR PharmGKB; PA142671690; -. DR VEuPathDB; HostDB:ENSG00000162669; -. DR eggNOG; KOG0952; Eukaryota. DR GeneTree; ENSGT00550000074822; -. DR HOGENOM; CLU_000335_0_0_1; -. DR InParanoid; A2PYH4; -. DR OMA; HCKNKHT; -. DR OrthoDB; 57056at2759; -. DR PhylomeDB; A2PYH4; -. DR TreeFam; TF328936; -. DR PathwayCommons; A2PYH4; -. DR BioGRID-ORCS; 164045; 9 hits in 1141 CRISPR screens. DR ChiTaRS; HFM1; human. DR GenomeRNAi; 164045; -. DR Pharos; A2PYH4; Tbio. DR PRO; PR:A2PYH4; -. DR Proteomes; UP000005640; Chromosome 1. DR RNAct; A2PYH4; Protein. DR Bgee; ENSG00000162669; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 101 other cell types or tissues. DR ExpressionAtlas; A2PYH4; baseline and differential. DR GO; GO:0005634; C:nucleus; IBA:GO_Central. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA. DR GO; GO:0003678; F:DNA helicase activity; IBA:GO_Central. DR GO; GO:0003676; F:nucleic acid binding; IEA:InterPro. DR GO; GO:0000712; P:resolution of meiotic recombination intermediates; IBA:GO_Central. DR CDD; cd18023; DEXHc_HFM1; 1. DR CDD; cd18795; SF2_C_Ski2; 1. DR Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2. DR Gene3D; 1.10.3380.10; Sec63 N-terminal domain-like domain; 1. DR Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1. DR InterPro; IPR011545; DEAD/DEAH_box_helicase_dom. DR InterPro; IPR014001; Helicase_ATP-bd. DR InterPro; IPR001650; Helicase_C. DR InterPro; IPR027417; P-loop_NTPase. DR InterPro; IPR004179; Sec63-dom. DR InterPro; IPR036388; WH-like_DNA-bd_sf. DR InterPro; IPR036390; WH_DNA-bd_sf. DR PANTHER; PTHR47835; HFM1, ATP DEPENDENT DNA HELICASE HOMOLOG; 1. DR PANTHER; PTHR47835:SF2; SEC63 DOMAIN-CONTAINING PROTEIN; 1. DR Pfam; PF00270; DEAD; 1. DR Pfam; PF00271; Helicase_C; 1. DR Pfam; PF02889; Sec63; 1. DR SMART; SM00487; DEXDc; 1. DR SMART; SM00490; HELICc; 1. DR SMART; SM00973; Sec63; 1. DR SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1. DR SUPFAM; SSF158702; Sec63 N-terminal domain-like; 1. DR SUPFAM; SSF46785; Winged helix' DNA-binding domain; 1. DR PROSITE; PS51192; HELICASE_ATP_BIND_1; 1. DR PROSITE; PS51194; HELICASE_CTER; 1. DR Genevisible; A2PYH4; HS. PE 1: Evidence at protein level; KW Alternative splicing; ATP-binding; Disease variant; Helicase; Hydrolase; KW Meiosis; Nucleotide-binding; Premature ovarian failure; Reference proteome. FT CHAIN 1..1435 FT /note="Probable ATP-dependent DNA helicase HFM1" FT /id="PRO_0000324393" FT DOMAIN 290..478 FT /note="Helicase ATP-binding" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00541" FT DOMAIN 519..720 FT /note="Helicase C-terminal" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00542" FT DOMAIN 777..1092 FT /note="SEC63" FT REGION 1109..1139 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1295..1315 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 411..414 FT /note="DEAH box" FT BINDING 303..310 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00541" FT VAR_SEQ 1..768 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_032249" FT VAR_SEQ 1295..1418 FT /note="GFGNTLSSSTRGSKLPLQESKSKFQREMSNSFVSSHEMSDISLSNSAMPKFS FT ASSMTKLPQQAGNAVIVHFQERKPQNLSPEIEKQCFTFSEKNPNSSNYKKVDFFIRNSE FT CKKEVDFSMYHPD -> VLFHHMRCRIFLYQILLCPSSVHPP (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_032250" FT VAR_SEQ 1419..1435 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_032251" FT VARIANT 115 FT /note="S -> P (in dbSNP:rs11165778)" FT /evidence="ECO:0000269|PubMed:17286053" FT /id="VAR_039799" FT VARIANT 117 FT /note="I -> V (in dbSNP:rs282009)" FT /evidence="ECO:0000269|PubMed:17286053" FT /id="VAR_039800" FT VARIANT 736 FT /note="G -> S (in POF9; dbSNP:rs587777269)" FT /evidence="ECO:0000269|PubMed:24597873" FT /id="VAR_071262" FT VARIANT 884 FT /note="I -> S (in POF9; dbSNP:rs587777268)" FT /evidence="ECO:0000269|PubMed:24597873" FT /id="VAR_071263" FT VARIANT 939 FT /note="I -> V (in dbSNP:rs11584478)" FT /id="VAR_049338" FT CONFLICT 408 FT /note="F -> L (in Ref. 1; BAF45466)" FT /evidence="ECO:0000305" FT CONFLICT 684 FT /note="C -> Y (in Ref. 1; BAF45466)" FT /evidence="ECO:0000305" SQ SEQUENCE 1435 AA; 162610 MW; 9FEFDF74FB990741 CRC64; MLKSNDCLFS LENLFFEKPD EVENHPDNEK SLDWFLPPAP LISEIPDTQE LEEELESHKL LGQEKRPKML TSNLKITNED TNYISLTQKF QFAFPSDKYE QDDLNLEGVG NNDLSHIAGK LTYASQKYKN HIGTEIAPEK SVPDDTKLVN FAEDKGESTS VFRKRLFKIS DNIHGSAYSN DNELDSHIGS VKIVQTEMNK GKSRNYSNSK QKFQYSANVF TANNAFSASE IGEGMFKAPS FSVAFQPHDI QEVTENGLGS LKAVTEIPAK FRSIFKEFPY FNYIQSKAFD DLLYTDRNFV ICAPTGSGKT VVFELAITRL LMEVPLPWLN IKIVYMAPIK ALCSQRFDDW KEKFGPIGLN CKELTGDTVM DDLFEIQHAH IIMTTPEKWD SMTRKWRDNS LVQLVRLFLI DEVHIVKDEN RGPTLEVVVS RMKTVQSVSQ TLKNTSTAIP MRFVAVSATI PNAEDIAEWL SDGERPAVCL KMDESHRPVK LQKVVLGFPC SSNQTEFKFD LTLNYKIASV IQMYSDQKPT LVFCATRKGV QQAASVLVKD AKFIMTVEQK QRLQKYAYSV RDSKLRDILK DGAAYHHAGM ELSDRKVVEG AFTVGDLPVL FTTSTLAMGV NLPAHLVVIK STMHYAGGLF EEYSETDILQ MIGRAGRPQF DTTATAVIMT RLSTRDKYIQ MLACRDTVES SLHRHLIEHL NAEIVLHTIT DVNIAVEWIR STLLYIRALK NPSHYGFASG LNKDGIEAKL QELCLKNLND LSSLDLIKMD EGVNFKPTEA GRLMAWYYIT FETVKKFYTI SGKETLSDLV TLIAGCKEFL DIQLRINEKK TLNTLNKDPN RITIRFPMEG RIKTREMKVN CLIQAQLGCI PIQDFALTQD TAKIFRHGSR ITRWLSDFVA AQEKKFAVLL NSLILAKCFR CKLWENSLHV SKQLEKIGIT LSNAIVNAGL TSFKKIEETD ARELELILNR HPPFGTQIKE TVMYLPKYEL KVEQITRYSD TTAEILVTVI LRNFEQLQTK RTASDSHYVT LIIGDADNQV VYLHKITDSV LLKAGSWAKK IAVKRALKSE DLSINLISSE FVGLDIQQKL TVFYLEPKRF GNQITMQRKS ETQISHSKHS DISTIAGPNK GTTASKKPGN RECNHLCKSK HTCGHDCCKI GVAQKSEIKE STISSYLSDL RNRNAVSSVP PVKRLKIQMN KSQSVDLKEF GFTPKPSLPS ISRSEYLNIS ELPIMEQWDQ PEIYGKVRQE PSEYQDKEVL NVNFELGNEV WDDFDDENLE VTSFSTDTEK TKISGFGNTL SSSTRGSKLP LQESKSKFQR EMSNSFVSSH EMSDISLSNS AMPKFSASSM TKLPQQAGNA VIVHFQERKP QNLSPEIEKQ CFTFSEKNPN SSNYKKVDFF IRNSECKKEV DFSMYHPDDE ADEMKSLLGI FDGIF //